Stockscreener 앱 받기
2.02
4.72%
-0.10
시간 외 거래:
2.05
0.03
+1.49%
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Healthcare's Convergence Accelerates as Aging Demographics Meet Breakthrough Therapies - Baystreet.ca
Revenue Check: Can Iovance Biotherapeutics Inc deliver consistent EPS growthTrade Entry Report & AI Enhanced Execution Alerts - خودرو بانک
Iovance Biotherapeutics (NASDAQ:IOVA) Share Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple - MSN
Published on: 2025-09-21 02:39:03 - خودرو بانک
Buy Signal: Can Iovance Biotherapeutics Inc grow without dilutionJuly 2025 Retail & AI Enhanced Execution Alerts - khodrobank.com
Valuation Update: Will Iovance Biotherapeutics Inc benefit from AI trendsMarket Activity Recap & Weekly Return Optimization Plans - خودرو بانک
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts - Insider Monkey
22,810 Stock Options at $2.20: Iovance Biotech Expands Team with New Employee Inducement Grants - Stock Titan
Returns Recap: Is Iovance Biotherapeutics Inc likely to announce a buybackDollar Strength & Low Risk High Reward Ideas - khodrobank.com
Decliners Report: Will Iovance Biotherapeutics Inc benefit from green energy policiesTrade Analysis Report & Weekly Watchlist of Top Performers - خودرو بانک
Can This Beaten-Down Stock Bounce Back? - Yahoo Finance
Ema's CHMP recommended five extensions of indication for medicines Bimervax, Dupixent, Keytruda - MarketScreener
Earnings Recap: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Earnings & Real-Time Buy Signal Alerts - خودرو بانک
Advancing Cancer Research Brings New Hope for Patients Worldwide - Benzinga
Bearish Setup: Can Iovance Biotherapeutics Inc stock double in the next yearJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - خودرو بانک
Sectors Review: Is Iovance Biotherapeutics Inc attractive at current valuationFed Meeting & Free Long-Term Investment Growth Plans - خودرو بانک
Why Iovance Biotherapeutics (IOVA) Is Up 8.2% After Health Canada Approves Amtagvi for Melanoma - Sahm
Aug Chart Watch: Is Iovance Biotherapeutics Inc being accumulated by smart moneyGap Up & Weekly Top Performers Watchlists - خودرو بانک
Iovance Biotherapeutics Updates Corporate Presentation - MSN
Aug Breakouts: Is Iovance Biotherapeutics Inc forming a bullish divergenceQuarterly Trade Report & Consistent Profit Trading Strategies - khodrobank.com
Fibrogen leads drug developer stock gains on China sale, FDA update - BioWorld MedTech
Is Iovance Biotherapeutics Inc showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - khodrobank.com
Nasdaq Moves: How does Iovance Biotherapeutics Inc score in quality rankingsJuly 2025 Highlights & Entry and Exit Point Strategies - خودرو بانک
Published on: 2025-09-16 06:42:56 - خودرو بانک
Entry Recap: Should I buy Iovance Biotherapeutics Inc. stock now2025 Technical Patterns & Weekly High Conviction Ideas - خودرو بانک
Market Overview: Can Iovance Biotherapeutics Inc. maintain sales growth2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک
Stock Analysis: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک
Bull Run: Will Iovance Biotherapeutics Inc benefit from AI trends2025 Geopolitical Influence & Entry and Exit Point Strategies - خودرو بانک
RSI Check: What are Iovance Biotherapeutics Inc.’s earnings expectationsEarnings Beat & Real-Time Volume Analysis - خودرو بانک
Iovance falls after missing Q2 expectation - MSN
Jacobs Levy Equity Management Inc. Invests $4.19 Million in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Hold" by Brokerages - MarketBeat
Iovance Biotherapeutics, Inc. $IOVA Position Cut by American Century Companies Inc. - MarketBeat
Why Iovance Biotherapeutics Stock Plummeted Today - MSN
Invenomic Capital Management LP Purchases Shares of 5,489,799 Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics at H.C. Wainwright Conference: Strategic Growth and Efficiency - Investing.com Canada
Growth Review: Will Iovance Biotherapeutics Inc. stock go up in YEARRisk Management & Stepwise Swing Trade Plans - Lancaster City Council
Is Iovance Biotherapeutics Inc. Forming a Consolidation BaseMarket Activity Report & Weekly Setup with High ROI Potential - beatles.ru
Iovance Biotherapeutics, Inc. $IOVA Shares Sold by Hsbc Holdings PLC - Defense World
H.C. Wainwright Keeps Buy Rating on Iovance (IOVA) After Health Canada Authorization News - Yahoo Finance
Is Iovance Biotherapeutics Inc. a turnaround storyJuly 2025 Pullbacks & Fast Gaining Stock Strategy Reports - beatles.ru
Iovance Biotherapeutics Soars as Health Canada Approves Amtagvi T Cell Therapy - StocksToTrade
Iovance Biotherapeutics Leaps Forward with Health Canada Approval - timothysykes.com
2.43%
자본화:
|
볼륨(24시간):